EXAS vs UMBFO
EXACT Sciences Corporation (EXAS) versus UMB Financial Corporation (UMBFO) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
UMB Financial Corporation (UMBFO) is a banks - regional company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
UMBFO does not have a complete income-statement cache yet.
EXAS currently screens at market cap $20.03B. UMBFO currently screens at market cap $0.
Not investment advice. Open the EXAS and UMBFO stock pages for the full models.
Not investment advice.